MoneyWorks4Me

Lincoln Pharma reports Profit after tax of Rs 110.24 Mln, in the March 2022 quarter

19 May 2022 Evaluate
The sales surged to Rs. 1025.42 millions, up 28.88% for the March 2022 quarter as against Rs. 795.65 millions during the corresponding quarter previous year.A slender decline of -12.31% was recorded to Rs. 110.24  millions from Rs. 125.71 millions in the corresponding previous quarter.Operating profit surged to 193.26 millions from the corresponding previous quarter of 178.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1025.42 795.65 28.88 4720.79 4229.08 11.63 4720.79 4229.08 11.63
Other Income 18.91 23.86 -20.75 99.98 57.43 74.09 99.98 57.43 74.09
PBIDT 193.26 178.17 8.47 1054.68 927.83 13.67 1054.68 927.83 13.67
Interest 5.66 5.68 -0.35 14.51 15.52 -6.51 14.51 15.52 -6.51
PBDT 187.60 172.49 8.76 1040.17 912.31 14.01 1040.17 912.31 14.01
Depreciation 19.98 18.92 5.60 80.88 75.60 6.98 80.88 75.60 6.98
PBT 167.62 153.57 9.15 959.29 836.71 14.65 959.29 836.71 14.65
TAX 57.38 27.86 105.96 265.74 214.21 24.06 265.74 214.21 24.06
Deferred Tax 5.64 -3.57 -257.98 7.20 2.47 191.50 7.20 2.47 191.50
PAT 110.24 125.71 -12.31 693.55 622.50 11.41 693.55 622.50 11.41
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 18.85 22.39 -15.84 22.34 21.94 1.83 22.34 21.94 1.83
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..